U.S., Nov. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07948330) titled 'rTMS for Incontinence After Prostate Treatment' on Nov. 02.

Brief Summary: Incontinence after prostate treatment (IPT) affects up to 25% of men following radical prostatectomy or other prostate therapies, primarily resulting from sphincteric weakness and impaired neuromuscular control. Current management options, including behavioral therapy and surgical implants, are often limited by modest effectiveness or invasiveness. Emerging neuroimaging evidence demonstrates that the pelvic supplementary motor area (pSMA) in the brain plays a critical regulatory role in controlling pelvic floor muscles and urethral sphincter activity. This pr...